Skip to main content

Advertisement

SpringerLink
Log in

Guanfacine produces differential effects in frontal cortex compared with striatum: assessed by phMRI BOLD contrast

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Guanfacine (an alpha-2A adrenoreceptor agonist) is a drug of benefit in the treatment of attention deficit hyperactivity disorder (ADHD) (Taylor FB, Russo J, J Clin Psychopharmacol 21:223–228, 2001). Assessment of this drug using neuroimaging will provide information about the brain regions involved in its effects.

Objectives

The pharmacological magnetic resonance imaging blood oxygenation level dependent (BOLD) response was determined in rat brain regions following administration of guanfacine.

Methods

Male rats were individually placed into a 2.35 T Bruker magnet for 60 min to achieve basal recording of changes in signal intensity. Either saline (n = 9) or guanfacine (0.3 mg/kg, i.p.; n = 9) was then administered and recording was continued for a further 90 min. Data were analysed for BOLD effects using statistical parametric maps. Respiration rate, blood pressure and blood gases were monitored and remained constant throughout scanning.

Results

The main changes observed were negative BOLD effects in the caudate putamen and nucleus accumbens with positive BOLD effects in frontal association, prelimbic and motor cortex areas.

Conclusions

These data suggest that guanfacine can decrease neuronal activity in the caudate while increasing frontal cortex activity. This ability to change neuronal activity in specific areas of rat brain that are known to be impaired in ADHD (Solanto MV, Behav Brain Res 130:65–71, 2002) may contribute to guanfacine’s beneficial effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  • Allison JD, Meador KJ, Loring DW, Figueroa RE, Wright JC (2000) Functional MRI cerebral activation and deactivation during finger movement. Neurology 11;54(1):135–142

    Google Scholar 

  • Aoki C, Go CG, Venkatesan C, Kurose H (1994) Perikaryal and synaptic localization of alpha 2A-adrenergic receptor-like immunoreactivity. Brain Res 650:181–204

    Article  PubMed  CAS  Google Scholar 

  • Arnsten AF, Li BM (2005) Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry 1;57(11):1377–1384

    Article  CAS  Google Scholar 

  • Arnsten AF, Cai JX, Goldman-Rakic PS (1988) The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes. J Neurosci 8:4287–4298

    PubMed  CAS  Google Scholar 

  • Arnsten AF, Steere JC, Hunt RD (1996) The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder. Arch Gen Psychiatry 53:448–455

    PubMed  CAS  Google Scholar 

  • Arnsten AF, Steere JC, Jentsch DJ, Li BM (1998) Noradrenergic influences on prefrontal cortical cognitive function: opposing actions at postjunctional alpha 1 versus alpha 2-adrenergic receptors. Adv Pharmacol 42:764–767

    Article  PubMed  CAS  Google Scholar 

  • Avery RA, Franowicz JS, Studholme C, van Dyck CH, Arnsten AF (2000) The alpha-2A-adrenoceptor agonist, guanfacine, increases regional cerebral blood flow in dorsolateral prefrontal cortex of monkeys performing a spatial working memory task. Neuropsychopharmacology 23:240–249

    Article  PubMed  CAS  Google Scholar 

  • Bernardis LL, Bellinger LL (1996) The lateral hypothalamic area revisited: ingestive behavior. Neurosci Biobehav Rev 20:189–287

    Article  PubMed  CAS  Google Scholar 

  • Birrell JM, Brown VJ (2000) Medial frontal cortex mediates perceptual attentional set shifting in the rat. J Neurosci 20:4320–4324

    PubMed  CAS  Google Scholar 

  • Cai JX, Ma YY, Xu L, Hu XT (1993) Reserpine impairs spatial working memory performance in monkeys: reversal by the alpha 2-adrenergic agonist clonidine. Brain Res 614:191–196

    Article  PubMed  CAS  Google Scholar 

  • Carboni E, Silvagni A (2004) Dopamine reuptake by norepinephrine neurons: exception or rule? Crit Rev Neurobiol 16:121–128

    Article  PubMed  CAS  Google Scholar 

  • Carlson S, Tanila H, Rama P, Mecke E, Pertovaara A (1992) Effects of medetomidine, an alpha-2 adrenoceptor agonist, and atipamezole, an alpha-2 antagonist, on spatial memory performance in adult and aged rats. Behav Neural Biol 58:113–119

    Article  PubMed  CAS  Google Scholar 

  • Cash D, Lowe AS, Roberts TJ, Ireland MD, Williams SCR (2002) In vivo mapping of mouse brain response to d-amphetamine using bold contrast FMRI. J Psychopharmacol 16:A65

    Article  Google Scholar 

  • Chappell PB, Riddle MA, Scahill L, Lynch KA, Schultz R, Arnsten A, Leckman JF, Cohen DJ (1995) Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette’s syndrome: preliminary clinical experience. J Am Acad Child Adolesc Psych 34:1140–1146

    Article  CAS  Google Scholar 

  • Coull JT, Middleton HC, Robbins TW, Sahakian BJ (1995) Clonidine and diazepam have differential effects on tests of attention and learning. Psychopharmacology 120:322–332

    Article  PubMed  CAS  Google Scholar 

  • De Bruin JP, Feenstra MG, Broersen LM, Van Leeuwen M, Arens C, De Vries S, Joosten RN (2000) Role of the prefrontal cortex of the rat in learning and decision making: effects of transient inactivation. Prog Brain Res 126:103–113

    PubMed  Google Scholar 

  • De Vos H, Vauquelin G, De Keyser J, De Backer JP, Van Liefde I (1992) Regional distribution of alpha 2A- and alpha 2B-adrenoceptor subtypes in postmortem human brain. J Neurochem 58(4):1555–1560

    Article  PubMed  Google Scholar 

  • Dixon AL, Prior M, Morris PM, Shah YB, Joseph MH, Young AM (2005) Dopamine antagonist modulation of amphetamine response as detected using pharmacological MRI. Neuropharmacology 48:236–245

    Article  PubMed  CAS  Google Scholar 

  • Dollery CT, Davies DS (1980) Centrally acting drugs in antihypertensive therapy. Br J Clin Pharmacol 10(Suppl 1):5S–12S

    PubMed  Google Scholar 

  • Febo M, Segarra AC, Nair G, Schmidt K, Duong TQ, Ferris CF (2005) The neural consequences of repeated cocaine exposure revealed by functional MRI in awake rats. Neuropsychopharmacology 30(5):936–943

    Article  PubMed  CAS  Google Scholar 

  • Friedman HR, Goldman-Rakic PS (1988) Activation of the hippocampus and dentate gyrus by working-memory: a 2-deoxyglucose study of behaving rhesus monkeys. J Neurosci 8:4693–4706

    PubMed  CAS  Google Scholar 

  • Friston KJ, Holmes AP, Worsley KJ, Poline JP, Frith CD, Frackowiak RSJ (1995) Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 2:189–210

    Article  Google Scholar 

  • Gazzola C (1995) The effect of the alpha 2-adrenoceptor agonist, guanfacin, on energy expenditure, intake and deposition in rats. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 112(1):29–34

    Article  PubMed  CAS  Google Scholar 

  • Grijalba B, Callado LF, Javier Meana J, Garcia-Sevilla JA, Pazos A (1996) Alpha 2-adrenoceptor subtypes in the human brain: a pharmacological delineation of [3H]RX-821002 binding to membranes and tissue sections. Eur J Pharmacol 22;310(1):83–93

    Article  Google Scholar 

  • Harel N, Lee SP, Nagaoka T, Kim DS, Kim SG (2002) Origin of negative blood oxygenation level-dependent fMRI signals. J Cereb Blood Flow Metab 22(8):908–917

    Article  PubMed  Google Scholar 

  • Hennig J, Nauerth A, Friedburg H (1986) RARE imaging: a fast imaging method for clinical MR. Magn Reson Med 3:823–833

    PubMed  CAS  Google Scholar 

  • Hewitt KN, Shah YB, Prior MJ, Morris PG, Hollis CP, Fone KC, Marsden CA (2005) Behavioural and pharmacological magnetic resonance imaging assessment of the effects of methylphenidate in a potential new rat model of attention deficit hyperactivity disorder. Psychopharmacology 180(4):716–723

    Article  PubMed  CAS  Google Scholar 

  • Hunt RD, Arnsten AF, Asbell MD (1995) An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psych 34:50–54

    Article  CAS  Google Scholar 

  • Jakala P, Riekkinen M, Sirvio J, Koivisto E, Kejonen K, Vanhanen M, Riekkinen P Jr (1999) Guanfacine, but not clonidine, improves planning and working memory performance in humans. Neuropsychopharmacology 20:460–470

    Article  PubMed  CAS  Google Scholar 

  • Jarrard LE (1993) On the role of the hippocampus in learning and memory in the rat. Behav Neural Biol 60:9–26

    Article  PubMed  CAS  Google Scholar 

  • Jaskiw GE, Weinberger DR, Crawley JN (1991a) Microinjection of apomorphine into the prefrontal cortex of the rat reduces dopamine metabolite concentrations in microdialysate from the caudate nucleus. Biol Psychiatry 29:703–706

    Article  PubMed  CAS  Google Scholar 

  • Jaskiw GE, Tizabi Y, Lipska BK, Kolachana BS, Wyatt RJ, Gilad GM (1991b) Evidence for a frontocortical–septal glutamatergic pathway and compensatory changes in septal glutamate uptake after cortical and fornix lesions in the rat. Brain Res 550:7–10

    Article  PubMed  CAS  Google Scholar 

  • Jodo E, Suzuki Y, Kayama Y (2000) Selective responsiveness of medial prefrontal cortex neurons to the meaningful stimulus with a low probability of occurrence in rats. Brain Res 856:68–74

    Article  PubMed  CAS  Google Scholar 

  • Jones N, O’Neill MJ, Tricklebank M, Libri V, Williams SCR (2005) Examining the neural targets of the AMPA receptor potentiator LY404187 in the rat brain using pharmacological magnetic resonance imaging. Psychopharmacology 180:743–751

    Article  PubMed  CAS  Google Scholar 

  • Kalisch R, Elbel GK, Gossl C, Czisch M, Auer DP (2001) Blood pressure changes induced by arterial blood withdrawal influence bold signal in anesthesized rats at 7 Tesla: implications for pharmacologic MRI. Neuroimage 14:891–898

    Article  PubMed  CAS  Google Scholar 

  • Kalisch R, Delfino M, Murer MG, Auer DP (2005) The phenylephrine blood pressure clamp in pharmacologic magnetic resonance imaging: reduction of systemic confounds and improved detectability of drug-induced BOLD signal changes. Psychopharmacology 180:774–780

    Article  PubMed  CAS  Google Scholar 

  • Karreman M, Moghaddam B (1996) The prefrontal cortex regulates the basal release of dopamine in the limbic striatum: an effect mediated by ventral tegmental area. J Neurochem 66:589–598

    Article  PubMed  CAS  Google Scholar 

  • Keilholz SD, Silva AC, Raman M, Merkle H, Koretsky AP (2004) Functional MRI of the rodent somatosensory pathway using multislice echo planar imaging. Magn Reson Med 52(1):89–99

    Article  PubMed  Google Scholar 

  • Kesner RP (1989) Retrospective and prospective coding of information: role of the medial prefrontal cortex. Exp Brain Res 74:163–167

    Article  PubMed  CAS  Google Scholar 

  • Kirch W, Kohler H, Braun W (1980) Elimination of guanfacine in patients with normal and impaired renal function. Br J Clin Pharmacol 10(Suppl 1):33S–35S

    PubMed  Google Scholar 

  • Kolachana BS, Saunders RC, Weinberger DR (1995) Augmentation of prefrontal cortical monoaminergic activity inhibits dopamine release in the caudate nucleus: an in vivo neurochemical assessment in the rhesus monkey. Neuroscience 69:859–868

    Article  PubMed  CAS  Google Scholar 

  • Levy F, Swanson JM (2001) Timing, space and ADHD: the dopamine theory revisited. Aust N Z J Psychiatry 35:504–511

    Article  PubMed  CAS  Google Scholar 

  • Liu ZHM, Schmidt KF, Sicard KM, Duong TQ (2004) Imaging oxygen consumption in forepaw somatosensory stimulation in rats under isoflurane anesthesia. Magn Reson Med 52:277–285

    Article  PubMed  Google Scholar 

  • Louilot A, Le Moal M, Simon H (1989) Opposite influences of dopaminergic pathways to the prefrontal cortex or the septum on the dopaminergic transmission in the nucleus accumbens. An in vivo voltammetric study. Neuroscience 29:45–56

    Article  PubMed  CAS  Google Scholar 

  • Ma CL, Arnsten AF, Li BM (2005) Locomotor hyperactivity induced by blockade of prefrontal cortical alpha2-adrenoceptors in monkeys. Biol Psychiatry 57:192–195

    Article  PubMed  CAS  Google Scholar 

  • Marrs W, Kuperman J, Avedian T, Roth RH, Jentsch JD (2005) Alpha-2 adrenoceptor activation inhibits phencyclidine-induced deficits of spatial working memory in rats. Neuropsychopharmacology 30:1500–1510

    Article  PubMed  CAS  Google Scholar 

  • Mulder AB, Nordquist R, Orgut O, Pennartz CM (2000) Plasticity of neuronal firing in deep layers of the medial prefrontal cortex in rats engaged in operant conditioning. Prog Brain Res 126:287–301

    Article  PubMed  CAS  Google Scholar 

  • Muller U, Clark L, Lam ML, Moore RM, Murphy CL, Richmond NK, Sandhu RS, Wilkins IA, Menon DK, Sahakian BJ, Robbins TW (2005) Lack of effects of guanfacine on executive and memory functions in healthy male volunteers. Psychopharmacology 182:205–213

    Article  PubMed  CAS  Google Scholar 

  • Murase S, Grenhoff J, Chouvet G, Gonon FG, Svensson TH (1993) Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo. Neurosci Lett 157:53–56

    Article  PubMed  CAS  Google Scholar 

  • Newcorn JH, Schulz K, Harrison M, DeBellis MD, Udarbe JK, Halperin JM (1998) Alpha 2 adrenergic agonists. Neurochemistry, efficacy, and clinical guidelines for use in children. Pediatr Clin North Am 45:1022–1099, viii

    Article  Google Scholar 

  • Newton JM, Sunderland A, Gowland PA (2005) fMRI signal decreases in ipsilateral primary motor cortex during unilateral hand movements are related to duration and side of movement. NeuroImage 15;24(4):1080–1087

    Article  Google Scholar 

  • Ordy JM, Thomas GJ, Volpe BT, Dunlap WP, Colombo PM (1988) An animal model of human-type memory loss based on aging, lesion, forebrain ischemia, and drug studies with the rat. Neurobiol Aging 9:667–683

    PubMed  CAS  Google Scholar 

  • Posey DJ, Puntney JI, Sasher TM, Kem DL, McDougle CJ (2004) Guanfacine treatment of hyperactivity and inattention in pervasive developmental disorders: a retrospective analysis of 80 cases. J Child Adolesc Psychopharmacol 14:233–241

    Article  PubMed  Google Scholar 

  • Ruffin MP, Caulliez R, Nicolaidis S (1995) Parallel metabolic and feeding responses to lateral hypothalamic stimulation. Brain Res 700:121–128

    Article  PubMed  CAS  Google Scholar 

  • Saameli K, Jerie P, Scholtysik G (1982) Guanfacine and other centrally acting drugs in antihypertensive therapy; pharmacological and clinical aspects. Clin Exp Hypertens A 4:209–219

    PubMed  CAS  Google Scholar 

  • Sanger DJ (1983) An analysis of the effects of systemically administered clonidine on the food and water intake of rats. Br J Pharmacol 78(1):159–164

    PubMed  CAS  Google Scholar 

  • Scahill L, Chappell PB, Kim YS, Schultz RT, Katsovich L, Shepherd E, Arnsten AF, Cohen DJ, Leckman JF (2001) A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry 158:1067–1074

    Article  PubMed  CAS  Google Scholar 

  • Shah YB, Marsden CA (2004) The application of functional magnetic resonance imaging to neuropharmacology. Curr Opin Pharmacol 4:517–521

    Article  PubMed  CAS  Google Scholar 

  • Shah YB, Haynes L, Prior MJ, Marsden CA, Morris PG, Chapman V (2005) Functional magnetic resonance imaging studies of opioid receptor-mediated modulation of noxious-evoked BOLD contrast in rats. Psychopharmacology 180(4):761–773

    Article  PubMed  CAS  Google Scholar 

  • Shmuel A, Yacoub E, Pfeuffer J, Van de Moortele PF, Adriany G, Hu X, Ugurbil K (2002) Sustained negative BOLD, blood flow and oxygen consumption response and its coupling to the positive response in the human brain. Neuron 19;36(6):993–995

    Google Scholar 

  • Shmuel A, Augath M, Oeltermann A, Logothetis NK (2006) Negative functional MRI response correlates with decreases in neuronal activity in monkey visual area V1. Nat Neurosci 9(4):569–577

    Article  PubMed  CAS  Google Scholar 

  • Sicard K, Shen Q, Brevard ME, Sullivan R, Ferris CF, King JA, Duong TQ (2003) Regional cerebral blood flow and BOLD responses in conscious and anesthetized rats under basal and hypercapnic conditions: implications for functional MRI studies. J Cereb Blood Flow Metab 23:472–481

    Article  PubMed  CAS  Google Scholar 

  • Sicard KM, Duong TQ (2005) Effects of hypoxia, hyperoxia, and hypercapnia on baseline and stimulus-evoked BOLD, CBF, and CMRO2 in spontaneously breathing animals. NeuroImage 25:850–858

    Article  PubMed  Google Scholar 

  • Siggaard-Andersen O (1971) An acid-base chart for arterial blood with normal and pathophysiological reference areas. Scand J Clin Lab Invest 27:239–245

    PubMed  CAS  Google Scholar 

  • Skoubis PD, Hradil V, Chin CL, Luo Y, Fox GB, McGaraughty S (2006) Mapping brain activity following administration of a nicotinic acetylcholine receptor agonist, ABT-594, using functional magnetic resonance imaging in awake rats. Neuroscience 137:583–591

    Article  PubMed  CAS  Google Scholar 

  • Smith AT, Williams AL, Singh KD (2004) Negative BOLD in the visual cortex: evidence against blood stealing. Hum Brain Mapp 21(4):213–220

    Article  PubMed  Google Scholar 

  • Solanto MV (2002) Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research. Behav Brain Res 130:65–71

    Article  PubMed  CAS  Google Scholar 

  • Steward CA, Marsden CA, Prior MJ, Morris PG, Shah YB (2005) Methodological considerations in rat brain BOLD contrast pharmacological MRI. Psychopharmacology 180(4):687–704

    Article  PubMed  CAS  Google Scholar 

  • Swartz BE, Kovalik E, Thomas K, Torgersen D, Mandelkern MA (2000) The effects of an alpha-2 adrenergic agonist, guanfacine, on rCBF in human cortex in normal controls and subjects with focal epilepsy. Neuropsychopharmacology 23:263–275

    Article  PubMed  CAS  Google Scholar 

  • Taber MT, Fibiger HC (1993) Electrical stimulation of the medial prefrontal cortex increases dopamine release in the striatum. Neuropsychopharmacology 9:271–275

    PubMed  CAS  Google Scholar 

  • Taylor FB, Russo J (2001) Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 21:223–228

    Article  PubMed  CAS  Google Scholar 

  • Trendelenburg AU, Starke K, Limberger N (1994) Presynaptic alpha 2A-adrenoceptors inhibit the release of endogenous dopamine in rabbit caudate nucleus slices. Naunyn Schmiedeberg’s Arch Pharmacol 350:473–481

    CAS  Google Scholar 

  • Tsujii S, Bray GA (1992) Food intake of lean and obese Zucker rats following ventricular infusions of adrenergic agonists. Brain Res 587:226–232

    Article  PubMed  CAS  Google Scholar 

  • Tuor UI, McKenzie E, Tomanek B (2002) Functional magnetic resonance imaging of tonic pain and vasopressor effects in rats. Magn Reson Imaging 20:707–712

    Article  PubMed  CAS  Google Scholar 

  • Uhlen S, Lindblom J, Tiger G, Wikberg JE (1997) Quantification of alpha2A and alpha2C adrenoceptors in the rat striatum and in different regions of the spinal cord. Acta Physiol Scand 160:407–412

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgement

This work was funded by Shire Pharmaceuticals.

Author information

Authors and Affiliations

  1. School of Biomedical Sciences, Medical School, Institute of Neuroscience, University of Nottingham, Queens Medical Centre, Nottingham, NG7 2UH, UK

    Neil Easton, Kevin C. Fone & Charles A. Marsden

  2. Institute of Neuroscience, Sir Peter Mansfield Magnetic Resonance Centre, University of Nottingham, University Park, Nottingham, UK

    Yasmene B. Shah

  3. Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge, CB1 2QJ, UK

    Fiona H. Marshall

Authors
  1. Neil Easton
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yasmene B. Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fiona H. Marshall
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kevin C. Fone
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Charles A. Marsden
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Neil Easton.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Easton, N., Shah, Y.B., Marshall, F.H. et al. Guanfacine produces differential effects in frontal cortex compared with striatum: assessed by phMRI BOLD contrast. Psychopharmacology 189, 369–385 (2006). https://doi.org/10.1007/s00213-006-0558-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-006-0558-1

Keywords

Search

Navigation